Niko Skievaski

Niko Skievaski is a seasoned entrepreneur with extensive experience in the health tech and nonprofit sectors. Currently serving as Co-Founder and CEO of Althea since September 2023, Niko focuses on the impact of psychedelic programs on health and consciousness. Niko also reports on psychedelics for Boulder Weekly and holds a board member position at Prime Health, where interim CEO responsibilities were previously undertaken. As a co-founder of Boulder Health Tech, Niko fosters community engagement in health and biotech. Previously, Niko co-founded and served as President of Redox, which streamlined healthcare data exchange, and contributed to various organizations such as People Everywhere Podcast, Porter Metrics, Forbes Technology Council, RISE Wisconsin, and 100state. Niko holds an M.A. in Economics from Boston University and a B.S. in Economics and International Business from ASU, complemented by a certificate in Artificial Intelligence from MIT Sloan School of Management.